Overview

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effects of the combination of fluvastatin and fenofibrate on dyslipidemia in comparison to the combination of simvastatin and ezetimibe.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Ezetimibe
Fenofibrate
Fluvastatin
Simvastatin